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Cheddar cheese was prepared with Lactococcus lactis subsp. lactis MM217, a starter culture which contains
pMC117 coding for pediocin PA-1. About 75 liters of pasteurized milk (containing ca. 3.6% fat) was inoculated
with strain MM217 (ca. 106 CFU per ml) and a mixture of three Listeria monocytogenes strains (ca. 103 CFU
per ml). The viability of the pathogen and the activity of pediocin in the cheese were monitored at appropriate
intervals throughout the manufacturing process and during ripening at 8°C for 6 months. In control cheese
made with the isogenic, non-pediocin-producing starter culture L. lactis subsp. lactis MM210, the counts of the
pathogen increased to about 107 CFU per g after 2 weeks of ripening and then gradually decreased to about 103
CFU per g after 6 months. In the experimental cheese made with strain MM217, the counts of L. monocytogenes
decreased to 102 CFU per g within 1 week of ripening and then decreased to about 10 CFU per g within 3
months. The average titer of pediocin in the experimental cheese decreased from approximately 64,000 arbi-
trary units (AU) per g after 1 day to 2,000 AU per g after 6 months. No pediocin activity (<200 AU per g) was
detected in the control cheese. Also, the presence of pMC117 in strain MM217 did not alter the cheese-making
quality of the starter culture, as the rates of acid production, the pH values, and the levels of moisture, NaCl,
and fat of the control cheese and the experimental cheese were similar. Our data revealed that pediocin-pro-
ducing starter cultures have significant potential for protecting natural cheese against L. monocytogenes.
Advances in genetic technologies have made it possible to
develop lactic acid bacteria (LAB) starter cultures or adjuncts
with enhanced fermentation characteristics, such as increased
phage resistance, improved proteolytic activity, and faster acid
production (16, 25). Genetically enhanced dairy cultures may
also extend the shelf life and/or improve the safety of the
resulting cheese through the production of various antimicro-
bials, notably bacteriocins. At present, nisin, which is produced
by Lactococcus lactis subsp. lactis, is the only bacteriocin ap-
proved for direct incorporation into cheese (6). However, com-
pared to non-nisin-producing starter cultures, some nisin-pro-
ducing starter cultures display slower lactose metabolism, less
proteolytic activity, lower heat resistance, and greater sensitiv-
ity to phage attacks (18–20). Nisin and other bacteriocins may
also be antagonistic towards mesophilic lactococci (non-bacte-
riocin-producing strains) used in mixed-strain starters or to-
wards nonstarter lactic acid bacteria (NSLAB) important in
flavor development. Thus, there has been continued interest in
developing commercial starter cultures with the ability to pro-
duce bacteriocins to ensure adequate performance of the start-
er and enhance the quality and safety of the resulting cheese.
Several investigators have evaluated the potential of bacte-
riocin-producing starters or starter adjuncts, especially lacto-
cocci, enterococci, and lactobacilli, to enhance performance
and/or control undesirable microbes in cheese. Cheddar cheese
made with a paired nisin-producing Lactococcus starter system
has been used successfully as an antimicrobial agent in pas-
teurized process cheese and cheese spreads to control Clos-
tridium sporogenes, Listeria monocytogenes, and Staphylococcus
aureus (34). Sulzer and Busse (31) used lactococci, enterococci,
or lactobacilli that were inhibitory to L. monocytogenes, alone
or in combination with commercial starter cultures, to con-
trol this pathogen in Camembert cheese. Listeriae were sup-
pressed only when the inhibitory strain was the sole starter and
when contamination with Listeria spp. occurred early during
ripening. Appreciable inhibition of L. monocytogenes in Cam-
embert cheese was also observed when a nisin-producing
paired lactococcal starter system was used (20). In the study of
Ryan et al. (28), sufficient lacticin 3147 was produced during
cheese manufacturing and ripening to have an impact on the
resident microflora; however, the full potential of the bacteri-
ocin was not substantiated against a food-borne pathogen, such
as L. monocytogenes, in cheese.
In studies of dairy applications of other bacteriocinogenic
cultures, Eppert et al. (8) used a linocin-producing Brevibac-
terium linens strain to obtain a 1- to 2-log10 reduction in the
amount of L. monocytogenes in soft, smear-ripened cheese, and
Joosten and Nunez (15) used bacteriocin-producing entero-
cocci and nisin-producing L. lactis strains separately to inhibit
the growth and production of histamine by Lactobacillus buch-
neri St2A in Manchego cheese. In Taleggio cheese, an entero-
cin-producing starter adjunct resulted in an appreciable de-
crease in the number of L. monocytogenes cells compared to
control cheese (11), while an enterocin-producing adjunct cul-
ture, Enterococcus faecalis INIA 4, accelerated flavor forma-
tion in semihard cheese (10). It should be noted, however, that
enterococci may not be desirable for routine application in
cheese making because some isolates (i) may produce tyra-
mine, (ii) may be responsible for clinical infections, (iii) may
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inhibit NSLAB involved in cheese ripening, and/or (iv) may be
used as indicators of fecal contamination (1).
Uljas and Luchansky (32) reported that lacticin 99, which
was produced by the starter adjunct Lactobacillus plantarum
JBL2132, inhibited NSLAB that form calcium lactate crystals
in Cheddar cheese. Other investigators reported that using a
commercial bacteriocinogenic mixture of L. plantarum strains
resulted in a 2-log10 reduction in the number of S. aureus cells
in 10 days during Montasio cheese ripening at 12°C compared
to the control, in which the number of pathogen cells increased
slightly (30). In addition, isolation from cheese of L. plantarum
WHE 92, which produces a pediocin, may provide additional
opportunities to use bacteriocinogenic lactobacilli as starters
or starter adjuncts in cheese (7). Lactobacilli can play a
significant role in flavor development in cheese, and unlike
hemolytic or cytolytic enterococci, lactobacilli do not pose a
significant threat to human health. Thus, identification of bac-
teriocinogenic lactobacilli and optimization of these organisms
as adjunct cultures could have an appreciable impact on the
quality and safety of several varieties of natural cheese.
With the possible exceptions of nisin and lactococci, pedi-
ocins and/or pediococci have been used more extensively to
control undesirable microbes in foods than any other biopre-
servatives (23, 29). Pediococcus spp. typically ferment lactose
poorly and are not known for their proteolytic ability in milk;
thus, they are used primarily as starter cultures for meat fer-
mentations (4). The genes coding for pediocin PA-1 (also
known as pediocin AcH), a class II, heat-labile, small, peptide
bacteriocin produced by Pediococcus acidilactici, have been
sequenced and subcloned into vectors suitable for expression
in other bacterial hosts, including lactococci (3, 5, 14, 22, 33).
Pediocin PA-1 was expressed under the control of the strong
lactococcal promoter P32 on pMC117 by L. lactis in microbi-
ological media (5). To more fully exploit the commercial po-
tential of a pediocin-producing lactococcal starter culture, in
the present study we evaluated the efficacy of L. lactis subsp.
lactis MM217 (containing pMC117) for controlling L. mono-
cytogenes during the manufacture and ripening of Cheddar
cheese.
MATERIALS AND METHODS
Bacterial strains. L. lactis subsp. lactis MM210 (Lac1 Prt1; Rhone-Poulenc
Marschall Products, Madison, Wis.) was passaged twice in 11% nonfat dry milk
(Carnation; Nestle Food Co., Glendale, Calif.) overnight at 32°C prior to inoc-
ulation into M17 (Difco Laboratories Inc., Detroit, Mich.) broth containing 0.5%
lactose (LM17 broth). L. lactis LL108 (Lac2 Prt2 RepA1) (17), the source of
plasmid pMC117 (Emr; 7.1 kb) carrying the pediocin PA-1 operon (ped) (5), was
passaged twice in M17 broth containing 0.5% glucose and 5 mg of erythromycin
(Sigma Chemical Co., St. Louis, Mo.) per ml at 30°C overnight prior to use.
L. monocytogenes JBL1003 (5 103M) (serotype 1/2c; meat isolate), JBL1181
(5 Ohio) (serotype 4b; cheese isolate), and JBL1180 (5 California) (serotype
4b; cheese isolate), which were obtained from the University of Wisconsin Food
Research Institute, were each passaged twice in brain heart infusion (Difco)
broth at 37°C overnight prior to use. To prepare a mixture of the three L. mono-
cytogenes strains, 1-ml portions of the three freshly grown L. monocytogenes
strains were mixed thoroughly in a test tube.
Isolation, transfer, and digestion of plasmid DNA. Plasmid DNA was isolated
from lactococci by the method of O’Sullivan and Klaenhammer (24). Restriction
enzymes were purchased from Promega Corporation (Madison, Wis.) and were
used as recommended by the manufacturer. Electrotransformation of lactococci
was performed essentially as described by Holo and Nes (13). The electroporated
cells (40 ml) were immediately mixed with 960 ml of ice-cold expression broth
(LM17 containing 0.5 M sucrose, 20 mM MgCl2, and 2 mM CaCl2) and then
incubated at 25°C for 1 to 3 h. Cells were spread plated onto selective strepto-
coccal regeneration medium (13) agar plates containing 5 mg of erythromycin per
ml and incubated at 32°C. Erythromycin-resistant electrotransformants were
transferred with sterile toothpicks onto LM17 agar plates without erythromycin
and incubated overnight at 32°C, and then the resulting colonies were overlaid
with 8 ml of tryptose phosphate (Difco) soft agar (containing 0.8% agar) seeded
with 3 ml of the three-strain L. monocytogenes mixture per ml. After overnight
incubation at 37°C, colonies exhibiting a zone of inhibition were streak plated
onto erythromycin-containing LM17 agar plates to obtain pure colonies. A rep-
resentative isolate, designated L. lactis subsp. lactis MM217, was grown overnight
at 32°C in LM17 broth containing 5 mg of erythromycin per ml and was used for
cheese-making experiments.
Cheddar cheese manufacturing. A standard protocol, obtained from Mark E.
Johnson (University of Wisconsin), was used for Cheddar cheese manufacturing.
Briefly, about 75 liters (78 kg) of pasteurized cheese milk (containing ca. 3.6%
fat) in a 300-liter stainless steel vat (Nu-Vat; Meyer-Blanke Co., St. Louis, Mo.)
surrounded by a steam-controlled water jacket was inoculated with about 6.6 3
106 CFU of L. lactis subsp. lactis MM210 or MM217 previously grown in LM17
broth per ml. About 10 min after the addition of the starter culture, the cheese
milk was also inoculated with about 103 CFU of the L. monocytogenes mixture
per ml. After 5 min of constant stirring with a long-handled plastic paddle, a
10-ml sample of the cheese milk was obtained and used for microbiological and
pediocin activity analyses. Drained whey at the cooking stage was also analyzed
for pediocin activity. The resulting curds (about 10.5 kg [13.5% yield] per 75 liters
of cheese milk) were pressed (25 lb/in2) at room temperature (25°C) for 5 to 6 h,
placed into oxygen-impermeable bags (Liquiflex grade 8226-I; Curwood, Osh-
kosh, Wis.), vacuum packaged (Multivac type AGW; KOCH, Kansas City, Mo.),
and then ripened at 8°C for up to 6 months. The cheese was made in the
pathogen-compatible food processing laboratory of the University of Wisconsin
Food Research Institute. All materials and equipment were autoclaved before
and after cheese making. The whey was cooked at 100°C for several hours, and
the remaining curds and cheese were autoclaved before they were discarded to
eliminate residual bacterial cells.
Bacteriocin assay. Trypticase soy (Difco) agar plates were overlaid with 8 ml
of Trypticase soy soft agar (containing 0.8% agar) seeded with 24 ml of freshly
grown indicator cells (L. monocytogenes mixture). Ten grams of cheese in a
stomacher bag (Seward Medical, London, United Kingdom) containing 90 ml of
a warm (45°C) 2% sodium citrate solution was macerated for 3 min with a model
400 stomacher (Tekmar Co., Cincinnati, Ohio). Serial twofold dilutions in sterile
double-distilled H2O were analyzed for pediocin activity essentially as described
by Pucci et al. (26) by using the L. monocytogenes strains in the mixture sepa-
rately as indicators. Activity was expressed in arbitrary units (AU) (the inverse of
the highest dilution that produced a discernible inhibition zone) (26).
Analyses of cheese. Cheese samples were obtained daily for 7 days and then
weekly for 7 weeks and after 3 and 6 months. With a sterile kitchen knife, a cube
(6.0 by 6.0 by 0.5 cm) was randomly cut from each of six sides of a cheese block.
In addition, a core sample (2.0 by 2.0 by 3.0 cm) was removed from the interior
of the cheese block. The cheese cubes and core (total weight, approximately
200 g) were placed into a stomacher bag and minced with a sterile knife. The
resulting pieces were mixed thoroughly, and then a 10-g portion was removed
and placed into another stomacher bag and macerated. Serial dilutions of the
homogenized mixture in 0.1% peptone water were spread plated onto listeria
enrichment (Difco) agar for enumeration of L. monocytogenes or onto LM17
agar and LM17 agar containing 5 mg of erythromycin per ml for enumeration of
L. lactis subsp. lactis MM210 and MM217, respectively. The listeria enrichment
agar plates were incubated at 37°C for 48 h, and the LM17 agar plates were
incubated at 32°C for 18 to 24 h before colonies were counted. The macerated
cheese samples were also tested for pediocin activity. The pH and the moisture,
salt, and fat levels of the Cheddar cheese were determined as described in
Standard Methods for the Examination of Dairy Products (21).
RESULTS
Expression of the pediocin operon in L. lactis subsp. lactis
MM210. L. lactis subsp. lactis MM210 was electrotransformed
with pMC117 to generate a pediocin-producing lactococcal
starter culture. When the resulting Emr cells of strain MM210
were overlaid with the three-strain L. monocytogenes mixture,
inhibition zones were observed around some of the colonies.
Inhibition zones were not observed when 5 ml of proteinase K
(0.1 mg/ml) was spotted next to the colonies, indicating that
the inhibitory substance was proteinaceous. Also, inhibition
zones were not observed when untransformed colonies of
L. lactis subsp. lactis MM210 were overlaid with the three-
strain L. monocytogenes mixture. Analyses of plasmid DNA
isolated from the Emr electrotransformants that exhibited in-
hibition zones revealed the presence of a 7.1-kb plasmid which
contained a 3.5-kb SmaI-BamHI fragment, as expected for
pMC117 (data not shown). A representative electrotrans-
formant, designated L. lactis subsp. lactis MM217, was used for
further analyses.
Survival of L. monocytogenes in Cheddar cheese made with
L. lactis subsp. lactis MM210 or MM217. In experimental
cheese made with L. lactis subsp. lactis MM217, the number of
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L. monocytogenes cells steadily decreased from the initial level,
3.5 log10 CFU per g, to about 2.0 log10 CFU per g within 7 days
and to about 1.0 log10 CFU per g after 184 days of ripening
(Table 1). In contrast, in cheese made with the isogenic non-
bacteriocinogenic starter culture, L. lactis subsp. lactis MM210,
the number of L. monocytogenes cells increased in the first 7
days of ripening, after which the number of pathogen cells
gradually decreased to about 4.0 log10 CFU per g after 184
days of ripening. In general, after 184 days of ripening at 8°C,
the number of L. monocytogenes cells in the experimental
cheese made with the bacteriocinogenic starter culture was at
least 3.0 log10 lower than the number of such cells in control
cheese made with the nonbacteriocinogenic starter culture.
There was no difference between the number of LAB on M17
agar plates (all LAB, including strain MM210 or MM217)
and the number of LAB on M17 agar containing erythro-
mycin, indicating that the inhibitory activity produced by strain
MM217 was not self-inhibitory or inhibitory to other NSLAB
(data not shown).
Recovery of pediocin activity from Cheddar cheese. When
the bacteriocinogenic starter L. lactis subsp. lactis MM217 was
added to cheese milk, the level of inhibitory activity detected
was 200 AU per ml. Although some inhibitory activity was lost
in the whey, a considerable amount remained with the cheese
after 1 day of ripening (Table 1). The level of inhibitory activity
remained at 64,000 AU per g during the first 14 days of rip-
ening and then gradually decreased. The decrease in the level
of recoverable inhibitory activity corresponded to the decrease
in the pathogen counts. In all cases, the level of activity de-
creased when proteinase K (0.1 mg/ml) was added to the test
mixture, indicating that the inhibitory substance was protein-
aceous. As inhibitory activity was not detected (the detection
limit was 200 AU per ml or 200 AU per g) during the manu-
facturing or ripening of the control cheese and as the strains
used in this study are isogenic (that is, they differ only in the
presence of the ped operon), we concluded that pediocin was
the inhibitory substance.
Analyses of Cheddar cheese composition. Proximate analy-
ses of each cheese within 1 week after ripening at 8°C showed
that it conformed to the standard of identity for Cheddar
cheese (2) and that there were no appreciable differences
between the composition of the control cheese (32% mois-
ture, 36% fat, 1.3% salt, pH 5.2; n 5 1) and the composition
of the experimental cheese (31.3% 6 1.25% moisture, 36.3%
6 0.94% fat, 1.26% 6 0.05% salt, pH 5.1 6 0.05; n 5 3).
DISCUSSION
L. monocytogenes has caused numerous outbreaks and spo-
radic cases of listeriosis worldwide, and some of these have
been attributed to dairy products (9). A national survey con-
ducted in England and Wales showed that although most soft-
ripened, unripened, or hard cheeses made from pasteurized or
unpasteurized milk contained ,10 CFU of Listeria spp. per g,
12% of the samples contained .103 L. monocytogenes CFU
per g (12). The threat of listeriosis may be increased by the
ability of L. monocytogenes to persist in certain cheeses, some-
times for extended periods of time (9). Thus, the purpose of
the present study was to construct a pediocin-producing lacto-
coccal starter culture and evaluate its antilisterial potential in
Cheddar cheese. Advantageous characteristics, such as heat
stability, as well as retention of activity at pH 5.1 and/or at
refrigeration temperatures, extend the utility of pediocin as a
biopreservative for cheese.
The pediocin-producing plasmid pMC117 was originally
cloned into L. lactis LL108; however, this strain is both pro-
teinase negative and lactose negative and is incapable of ade-
quate growth and acid production in milk (5). In the present
study, L. lactis subsp. lactis MM210 was selected as an alternate
host for pMC117, as this strain is well characterized geneti-
cally, has a weakened but active host restriction and modifica-
tion system, and has previously been used in Cheddar cheese
manufacturing (27). The electrotransformed derivative of strain
MM210 containing pMC117, designated L. lactis subsp. lactis
MM217, had the same growth characteristics and acid-produc-
ing capability as the isogenic parental strain, L. lactis subsp.
lactis MM210 (data not shown). Also, the behavior of strain
MM217 was physiologically similar to the behavior of strain
MM210 during cheese manufacturing, indicating that the pres-
ence of pMC117 did not alter the cheese-making properties of
the original starter strain. More important, the level of survival
of L. monocytogenes in Cheddar cheese made with L. lactis
subsp. lactis MM217 was considerably lower than the level of
survival of the pathogen in the control cheese. Since no inhib-
itory activity was detected in the control cheese, in situ pro-
duction of pediocin by strain MM217 in the experimental
cheese was responsible for the appreciable decline in the num-
ber of L. monocytogenes cells. Although other investigators
established that preformed pediocin added to foods, including
cheese, was inhibitory to L. monocytogenes (23, 29), inhibition
of L. monocytogenes by in situ production of pediocin in Ched-
dar cheese by a lactococcal starter culture has not been re-
ported previously.
After 6 months of ripening at 8°C, the level of recoverable
pediocin activity decreased from 64,000 to 2,000 AU per g.
Garde et al. (10) also described a decrease in the recovery of
enterocin activity from a Hispanico type of cheese after 15 days
of ripening at 14°C. In contrast, Ryan et al. (28) reported that
the levels of lacticin 3147 remained relatively constant during
6 months of ripening at 8°C. The primary cause of the decline
in the pediocin titer after 6 months of ripening was probably
the sensitivity of pediocin to proteinases, in addition to autol-
ysis of the starter and release of peptidases. However, other
factors, including depletion of carbon and energy sources and
binding of pediocin to cheese components, may also have con-
tributed to the decrease in pediocin production and/or activity.
TABLE 1. Survival of L. monocytogenes and pediocin activities in
Cheddar cheese made with the bacteriocinogenic starter culture
L. lactis subsp. lactis MM217 (experimental cheese; n 5 3) or
the isogenic nonbacteriocinogenic starter culture L. lactis














Milk 3.22 200 3.51 6 0.26c
Curd after cooking 3.92 NS 4.01 6 0.52
Whey when drained NSd 3,200 NS
Curd after pressing 4.41 NS 3.65 6 0.33
Ripening 1 4.75 64,000 3.22 6 0.80
7 7.47 64,000 1.90 6 0.09
14 5.65 64,000 1.88 6 0.12
21 5.3 32,000 1.73 6 0.29
28 5.61 32,000 1.63 6 0.37
92 3.83 8,000 0.82 6 0.10
184 4.1 2,000 0.92 6 0.88
a Log10 CFU per milliliter or log10 CFU per gram.
b AU per milliliter or AU per gram.
c Mean 6 standard deviation.
d NS, no sample was obtained.
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Although the level of pediocin activity recovered from the
experimental cheese after 6 months of ripening at 8°C was
lower than the levels recovered earlier, the number of path-
ogen cells was reduced to ,10 CFU per g. As the residual
L. monocytogenes population did not increase, the persistence
of L. monocytogenes in an otherwise hostile environment could
be attributed in part to individual cells that were entrapped in
the casein matrix, which may have sequestered the pathogen
somewhat from exposure to pediocin. The residual L. mono-
cytogenes population may also have included a subpopulation
of pediocin-resistant cells that over a longer time period could
grow to levels sufficient to detect. However, it is also possible
that the low pH, low water activity, and low ripening temper-
ature provided additional hurdles which suppressed the growth
and survival of residual L. monocytogenes cells in Cheddar
cheese.
In conclusion, a genetically modified starter culture that pro-
duced pediocin in situ improved the microbiological safety
of Cheddar cheese contaminated with L. monocytogenes.
The acid-producing quality of the bacteriocinogenic starter
culture and the composition of the Cheddar cheese produced
with it were not altered by the acquisition of pMC117. In
addition, the Standard of Identity of Cheddar Cheese was
maintained, as pediocin was produced in situ and, thus, was not
considered an additive. The use of genetically enhanced starter
cultures that produce bacteriocins in situ may lessen microbi-
ological safety problems with foods that do not undergo high-
heat treatment and/or foods in which the use of chemical
preservatives is not suitable.
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